|
1
|
Antoniadou F, Korkolis D, Koufopoulos N,
Manatakis D and Sakellariou S: A well differentiated neuroendocrine
tumor of the jejunum with peritoneal carcinomatosis: A case report.
Mol Clin Oncol. 9:651–655. 2018.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Kim JY, Hong SM and Ro JY: Recent updates
on grading and classification of neuroendocrine tumors. Ann Diagn
Pathol. 29:11–16. 2017.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Dasari A, Shen C, Halperin D, Zhao B, Zhou
S, Xu Y, Shih T and Yao JC: Trends in the incidence, prevalence,
and survival outcomes in patients with neuroendocrine tumors in the
United States. JAMA Oncol. 3:1335–1342. 2017.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Yamaguchi T, Fujimori T, Tomita S,
Ichikawa K, Mitomi H, Ohno K, Shida Y and Kato H: Clinical
validation of the gastrointestinal NET grading system: Ki67 index
criteria of the WHO 2010 classification is appropriate to predict
metastasis or recurrence. Diagn Pathol. 8(65)2013.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Norlen O, Edfeldt K, Akerstrom G, Westin
G, Hellman P, Bjorklund P and Stalberg P: Peritoneal carcinomatosis
from small intestinal neuroendocrine tumors: Clinical course and
genetic profiling. Surgery. 156:1512–1521. 2014.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Wright MF, Cates J, Gonzales RS, Das S,
Berlin JD and Shi C: Impact of peritoneal metastasis on survival of
patients with small intestinal neuroendocrine tumor. Am J Surg
Pathol. 43:559–563. 2019.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Celotti A, Pulcini G, Schieppati M,
Ministrini S, Berruti A and Ronconi M: An unusual case of a
well-differentiated neuroendocrine tumour of the ileum with
peritoneal carcinomatosis: A case report. World J Surg Oncol.
13(169)2015.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Nagtegaal ID, Odze RD, Klimstra D, Paradis
V, Rugge M, Schirmacher P, Washington KM, Carneiro F and Cree IA:
WHO Classification of Tumours Editorial Board. The 2019 WHO
classification of tumours of the digestive system. Histopathology.
76:182–188. 2020.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Trikalinos NA, Tan BR, Amin M, Liu J,
Govindan R and Morgensztern D: Effect of metastatic site on
survival in patients with neuroendocrine neoplasm (NENs). An
analysis of SEER data from 2010 to 2014. BMC Endocr Disord.
20(44)2020.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Strosberg JR, Weber JM, Feldman M, Coppola
D, Meredith K and Kvols LK: . Prognostic validity of the American
joint committee on cancer staging classification for midgut
neuroendocrine tumors. J Clin Oncol. 31:420–425. 2013.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Das S, Shi C, Koyama T, Huang Y, Gonzalez
R, Idrees K, Bailey CE and Berlin J: Peritoneal carcinomatosis in
well-differentiated small-intestinal neuroendocrine tumors with
mesenteric tumor deposits. J Med Surg Pathol. 4:1–10.
2019.PubMed/NCBI
|
|
12
|
Desai JP and Moustarah F: Peritoneal
metastasis. In: StatPearls (Internet). StatPearls Publishing,
Treasure Island, FL, 2022. Available from: https://www.ncbi.nlm.nih.gov/books/NBK541114/.
|
|
13
|
van Baal JOAM, van Noorden CJF, Nieuwland
R, Van de Vijver KK, Sturk A, van Driel WJ, Kenter GG and Lok CAR:
Development of peritoneal carcinomatosis in epithelial ovarian
cancer: A review. J Histochem Cytochem. 66:67–83. 2018.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Sun X and Kaufman PD: Ki-67: More than a
proliferation marker. Chromosoma. 127:175–186. 2018.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Di Domenico A, Wiedmer T, Marinoni I and
Perren A: Genetic and epigenetic drives of neuroendocrine tumours
(NET). Endocr Relat Cancer. 24:R315–R334. 2017.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Berardi R, Morgese F, Torniai M, Savini A,
Partelli S, Rinaldi S, Caramanti M, Ferrini C, Falconi M and
Cascinu S: Medical treatment for gastro-entero-pancreatic
neuroendocrine tumours. World J Gastrointest Oncol. 8:389–401.
2016.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Simon-Gracia L, Hunt H and Teesalu T:
Peritoneal carcinomatosis targeting with tumor homing peptides.
Molecules. 23(1190)2018.PubMed/NCBI View Article : Google Scholar
|
